AstraZeneca (AZN): Q3 core EPS of $1.71 beats by $0.01. Revenue of $8.21B (+4% Y/Y) beats by...


AstraZeneca (AZN): Q3 core EPS of $1.71 beats by $0.01. Revenue of $8.21B (+4% Y/Y) beats by $50M. Net profit +124% to $3.48B, in line. Raises FY core EPS forecast to $7.20-$7.40 from $7.05-$7.35. Earnings benefited from favorable currency movements, sale of dental unit, and strong performances in emerging markets. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs